Catalio Capital Joins $130M Series B for GlycoEra's Autoimmune Therapies
May 29, 2025 — Catalio Capital invests in GlycoEra's $130M Series B for autoimmune disease treatments, signaling strong belief in biotech innovation.
Curated Health Wellness News
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
Catalio Capital Backs GlycoEra's $130M Series B for Autoimmune Therapies
May 29, 2025 — Catalio Capital joins a $130M Series B funding for GlycoEra, a biotech firm developing innovative treatments for autoimmune diseases, marking a significant step in life sciences investment.
TransCode Therapeutics Names Dr. Phillip D. Zamore to Scientific Advisory Board
May 28, 2025 — TransCode Therapeutics appoints Dr. Phillip D. Zamore, a leading figure in RNA research, to its Scientific Advisory Board. The addition enhances the company's focus on RNA-targeted cancer therapy programs, marking a strategic development in the fight against metastatic disease.
Bioadaptives Reveals Impressive Results for Regen(TM) Dog Chews in Clinical Trials
May 28, 2025 — Bioadaptives showcases remarkable clinical results for Regen(TM) Dog Chews, offering a safe and effective solution for improving canine health and vitality. With a 281.3% increase in circulating stem cells and a proprietary rating system, this premium pet wellness product stands out for its natural ingredients and proven benefits.
TransCode Therapeutics Appoints Dr. Phillip D. Zamore to Scientific Advisory Board
May 28, 2025 — TransCode Therapeutics appoints Dr. Phillip D. Zamore, a leading figure in RNA research, to its Scientific Advisory Board, enhancing its cancer therapy programs. The addition of Dr. Zamore underscores the company's commitment to developing innovative RNA therapeutics for metastatic disease.
House Passes Reconciliation Bill Impacting Healthcare and Medicaid
May 28, 2025 — The U.S. House of Representatives approval of the reconciliation bill for the 2025 budget with a one-vote difference will have significant impacts on healthcare insurance and Medicaid. Learn more about the potential changes and implications of this legislation.
Renowned RNA Expert Dr. Phillip D. Zamore Joins TransCode Therapeutics' Scientific Advisory Board
May 28, 2025 — Renowned RNA expert Dr. Phillip D. Zamore joins TransCode Therapeutics' Scientific Advisory Board, enhancing the company's cancer therapy programs. This strategic addition highlights the potential of RNA therapeutics for treating metastatic tumors and revolutionizing oncology.
Quantum BioPharma Receives Approval for Phase 2 Clinical Trial of FSD202 for Chronic Pain Associated with MCAS
May 28, 2025 — Quantum BioPharma (NASDAQ: QNTM) receives approval for Phase 2 clinical trial of FSD202, a potential treatment for chronic pain associated with MCAS. The trial aims to measure pain reduction over 56 days, offering hope for patients with this debilitating disorder.
NanoViricides to Present at BIO International Convention 2025, Showcasing Antiviral Drug Pipeline
May 28, 2025 — NanoViricides, Inc. (NNVC) to present at BIO International Convention 2025 in Boston, discussing antiviral drug pipeline including NV-387. Learn more about the company's innovative approach to viral treatment.
HCTI Secures Multi-Year Wins and Expands AI Services in Healthcare Sector
May 28, 2025 — Healthcare Triangle, Inc. (HCTI) announces new strategic contracts and AI advancements in the healthcare sector, positioning the company as a key player in digital transformation solutions for improved patient care.
Oragenics Announces 1-for-30 Reverse Stock Split to Enhance Market Profile
May 28, 2025 — Oragenics announces a 1-for-30 reverse stock split to boost share price and appeal to investors. CEO Janet Huffman aims to enhance the company's capital markets profile while advancing treatments for brain-related health conditions.
Study Reveals Variations in Sodium Intake Among Different Racial and Ethnic Groups in the U.S.
May 28, 2025 — New research reveals racial and ethnic disparities in sodium intake, emphasizing the need for customized advice. Understanding cultural differences in salt usage is crucial for reducing high blood pressure and cardiovascular disease risk.
Unchained Leader Program Recognized by Reuters for Positive Impact on Mental Health
May 28, 2025 — Unchained Leader program receives global recognition for positive impact on mental health. Founded by Mason Cain, the 90-day self-help program offers personalized treatment plans and a supportive community for lasting healing and freedom.
Houston's Homewatch CareGivers Ranked #1 in Houston, #7 Nationwide
May 27, 2025 — Homewatch CareGivers of Houston Galleria ranked #1 in Houston for in-home senior care, offering compassionate, nurse-guided services. Learn why they're trusted.
GeoVax Labs Emphasizes Multi-Antigen Vaccine for Vulnerable Populations
May 27, 2025 — GeoVax Labs announces strong support for FDA's updated COVID-19 vaccine recommendations, highlighting the importance of tailored vaccine solutions for vulnerable populations. Learn how the multi-antigen vaccine, GEO-CM04S1, aims to provide comprehensive immune responses in high-risk individuals.
New Swallowable Pill Revolutionizes Gut Health Monitoring
May 27, 2025 — Discover how a new swallowable pill is changing the game for gut health monitoring. Learn how advancements in tracking mucosal barrier integrity could revolutionize the diagnosis and treatment of gut-related conditions. Stay informed on the latest breakthroughs in healthcare technology.
The Maercks Institute: Where Innovation, Elegance, and Zero Pain Aesthetic Surgery Converge
May 27, 2025 — Discover the gold standard in aesthetic surgery at The Maercks Institute, where innovation and elegance meet for pain-free procedures and natural results. Dr. Rian Maercks' global perspective on beauty sets a new standard in patient care, providing a uniquely refined path to self-enhancement.
Nutriband CEO Discusses AVERSA(TM) Platform in BioMedWire Podcast
May 27, 2025 — Nutriband CEO Gareth Sheridan discusses the company's AVERSA(TM) platform in The BioMedWire Podcast, offering insights into transdermal drug delivery systems and pain management. Learn how Nutriband aims to improve safety and accessibility in the fentanyl patch market.
Healthcare Triangle Launches QuantumNexis for AI-powered Healthcare Solutions
May 27, 2025 — Healthcare Triangle, Inc. (HCTI) unveils QuantumNexis, a subsidiary focused on AI-powered SaaS solutions for healthcare. With the acquisition of Niyama Healthcare and Ezovion Solutions, HCTI aims to address global healthcare demands and lead in Gen AI-powered technology.
American Heart Association Initiative Targets Access to Gene Editing Therapies for Cardiomyopathy
May 27, 2025 — American Heart Association launches initiative to improve access to gene editing therapies for transthyretin amyloid cardiomyopathy (ATTR-CM) in underserved populations. Learn how this program aims to enhance patient care and outcomes for a specific heart condition.